Cathy Maes

730 citations
13 papers · 447 · h-index 11

Impact in

  • Epidemiology top 10%
    • Influenza Virus Research Studies
    • Pneumonia and Respiratory Infections
    • Respiratory viral infections research
  • Virology top 10%

Papers in

  • Epidemiology 10
    • Influenza Virus Research Studies 4
    • Respiratory viral infections research 3
    • Pneumonia and Respiratory Infections 2
  • Infectious Diseases 5
    • Viral gastroenteritis research and epidemiology 2
    • Tuberculosis Research and Epidemiology 1
Co-authors
Geert Leroux‐Roels (12 shared papers)Fien De Boever (7 shared papers)Emmanuel Hanon (2 shared papers)François Roman (2 shared papers)Isabel Leroux‐Roels (3 shared papers)Mamadou Dramé (2 shared papers)Julie Willekens (2 shared papers)Marcelle Van Mechelen (1 shared paper)
Journals
Vaccine (5 papers)Clinical and Vaccine Immunology (2 papers)Vaccines (1 paper)Clinical Infectious Diseases (1 paper)Frontiers in Immunology (1 paper)
Partner nations
BelgiumUnited StatesUnited Kingdom

In The Last Decade

Cathy Maes

12 papers receiving 435 citations

Peers

Cathy Maes
Comparison fields: 5 of 50
  • Epidemiology 298
  • Virology 34
  • Microbiology 35
  • Immunology 112
  • Infectious Diseases 80
Replace Jesse Bodle with:
Jesse Bodle Australia
Mohinder Sidhu United States
Fien De Boever Belgium
Rugimar Marcovistz Brazil
George A. Robertson United States
Helen May‐Lin Oh Singapore
Craig Thompson United Kingdom
Subhash V. Kapre India
Sarina Camuglia Australia
Mirian Fernández-Alonso Spain
Cathy Maes relative to Jesse Bodle Australia Jesse Bodle's profile →
Citations per field
00.5×2×3×3.7×
Jesse Bodle · 1×
Citations per year

Countries citing papers authored by Cathy Maes

Since Specialization
Citations

This map shows the geographic impact of Cathy Maes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Maes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Maes more than expected).

Fields of papers citing papers by Cathy Maes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Maes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Maes. The network helps show where Cathy Maes may publish in the future.

Co-authors

The 25 scholars most cited alongside Cathy Maes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cathy Maes Line = papers co-authored together Cathy Maes links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
Vaccine ·Isabel Leroux‐Roels, François Roman, Sheron Forgus, Cathy Maes, Fien De Boever, Mamadou Dramé, Paul Gillard, Robbert van der Most, Marcelle Van Mechelen, Emmanuel Hanon, Geert Leroux‐Roels
2009115
2
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
PLoS ONE ·Geert Leroux‐Roels, Cathy Maes, Frédéric Clément, Frank van Engelenburg, Marieke van den Dobbelsteen, Michael Adler, Mario Amacker, Lucia Lopalco, Morgane Bomsel, Anick Chalifour, Sylvain Fleury
201358
3
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study
Vaccine ·Geert Leroux‐Roels, Cathy Maes, Fien De Boever, Magali Traskine, J. Rüggeberg, Dorota Borys
201456
4
A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women
Vaccine ·Geert Leroux‐Roels, Cathy Maes, Julie Willekens, Fien De Boever, Richard de Rooij, Leah Martell, Lisa Bedell, Frederick Wittke, Karen S. Slobod, Peter Dull
201650
5
Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials
Clinical and Vaccine Immunology ·François Roman, Frédéric Clément, Walthère Dewé, Karl Walravens, Cathy Maes, Julie Willekens, Fien De Boever, Emmanuel Hanon, Geert Leroux‐Roels
201144
6
Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study
Vaccine ·Geert Leroux‐Roels, Fien De Boever, Cathy Maes, Thi Lien-Anh Nguyên, Sherryl Baker, Antonio López
201927
7
Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial
Clinical Infectious Diseases ·Geert Leroux‐Roels, Zourab Bebia, Cathy Maes, Annelies Aerssens, Fien De Boever, Luca Grassano, Giada Buffi, Immaculada Margarit, Annette Karsten, Stephen Cho, Karen S. Slobod, Bartholomew Corsaro, Ouzama Henry
201922
8
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
Frontiers in Immunology ·Isabel Leroux‐Roels, Cathy Maes, Jasper Joye, Bart Jacobs, Franziska Jarczowski, André Diessner, Yorick Janssens, Gwenn Waerlop, Kirsi Tamminen, Suvi Heinimäki, Vesna Blazevic, Geert Leroux‐Roels, Victor Klimyuk, Hiroshi Adachi, Kazuyuki Hiruta, Frank Thieme
202219
9
Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine
Clinical and Vaccine Immunology ·Geert Leroux‐Roels, Edwige Haelterman, Cathy Maes, Jack Lévy, Fien De Boever, Laurent Licini, Marie-Pierre David, Kurt Dobbelaere, Dominique Descamps
201118
10
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial
Vaccine ·Opokua Ofori‐Anyinam, Geert Leroux‐Roels, Mamadou Dramé, Annelies Aerssens, Cathy Maes, Arshad Amanullah, Anne Schuind, Ping Li, Varsha Jain, Bruce L. Innis
201718
11
Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine
Vaccines ·Isabel Leroux‐Roels, Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Jasper Joye, Cathy Maes, Paul‐Henri Lambert, Geert Leroux‐Roels
202311
12
Pregnancy has a minimal impact on the acute transcriptional signature to vaccination
npj Vaccines ·John S. Tregoning, January Weiner, Deniz Cizmeci, Danielle Hake, Jeroen Maertzdorf, Stefan H. E. Kaufmann, Geert Leroux‐Roels, Cathy Maes, Annelies Aerssens, Anna Calvert, Christine E. Jones
20208
13
IMMUNE REACTIVITY OF MYCOBACTERIUM BOVIS (STRAIN BCG) AND MYCOBACTERIUM VACCAE
M Rennou, Cathy Maes, H.H. Maes, Roland Maes, A R Hadi Zadeh Tasbiti, Sh. Yari, Ali Karimi, Shamsodin Niknami, A R Bahrehmand
20041

About Cathy Maes

Cathy Maes is a scholar working on Epidemiology, Infectious Diseases, Immunology, Public Health, Environmental and Occupational Health and Surgery, having authored 13 papers that have together received 447 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (4 papers), Respiratory viral infections research (3 papers), Neonatal and Maternal Infections (2 papers), Pneumonia and Respiratory Infections (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Immune Response and Inflammation (2 papers), Tuberculosis Research and Epidemiology (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Epidemiology (298 citations), Virology (34 citations), Microbiology (35 citations), Immunology (112 citations) and Infectious Diseases (80 citations). Cathy Maes has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Geert Leroux‐Roels, Fien De Boever, Emmanuel Hanon, François Roman, Isabel Leroux‐Roels, Mamadou Dramé, Julie Willekens, Marcelle Van Mechelen, Robbert van der Most and Paul Gillard. Their work appears in journals such as Vaccine, Clinical and Vaccine Immunology, Vaccines, Clinical Infectious Diseases and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesse BodleBreakdown of academic impact, for papers by Mohinder SidhuBreakdown of academic impact, for papers by Fien De BoeverBreakdown of academic impact, for papers by Rugimar MarcovistzBreakdown of academic impact, for papers by George A. RobertsonBreakdown of academic impact, for papers by Helen May‐Lin OhBreakdown of academic impact, for papers by Craig ThompsonBreakdown of academic impact, for papers by Subhash V. KapreBreakdown of academic impact, for papers by Sarina CamugliaBreakdown of academic impact, for papers by Mirian Fernández-Alonso